X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (541) 541
Publication (52) 52
Book / eBook (8) 8
Book Chapter (7) 7
Web Resource (6) 6
Book Review (2) 2
Conference Proceeding (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (326) 326
female (303) 303
oncology (292) 292
breast cancer (230) 230
index medicus (216) 216
breast neoplasms - drug therapy (209) 209
middle aged (161) 161
breast neoplasms - pathology (140) 140
aged (127) 127
adult (120) 120
chemotherapy (119) 119
cancer (116) 116
prognosis (95) 95
trastuzumab (94) 94
treatment outcome (94) 94
chemotherapy, adjuvant (92) 92
breast neoplasms - genetics (90) 90
antineoplastic combined chemotherapy protocols - therapeutic use (83) 83
disease-free survival (82) 82
antineoplastic agents - therapeutic use (80) 80
therapy (64) 64
clinical trials (62) 62
research (61) 61
breast neoplasms - mortality (60) 60
care and treatment (60) 60
tumors (58) 58
breast neoplasms - metabolism (55) 55
hematology, oncology and palliative medicine (53) 53
survival (53) 53
drug therapy (51) 51
receptor, erbb-2 - metabolism (50) 50
adjuvant chemotherapy (49) 49
metastasis (48) 48
gene expression (40) 40
neoplasm staging (40) 40
postmenopausal women (39) 39
analysis (38) 38
gene expression profiling (38) 38
survival analysis (38) 38
paclitaxel (37) 37
tamoxifen (36) 36
breast neoplasms - therapy (35) 35
patients (35) 35
aged, 80 and over (34) 34
medicine & public health (34) 34
breast neoplasms - chemistry (33) 33
docetaxel (33) 33
women (32) 32
antibodies, monoclonal, humanized (31) 31
antineoplastic combined chemotherapy protocols - adverse effects (31) 31
cancer therapies (31) 31
drug administration schedule (31) 31
lapatinib (31) 31
risk factors (31) 31
estrogen (30) 30
her2 (30) 30
randomized controlled trials as topic (30) 30
receptor, erbb-2 - analysis (29) 29
antineoplastic agents - adverse effects (28) 28
biomarkers, tumor - analysis (28) 28
breast (28) 28
clinical trials as topic (28) 28
genetic aspects (28) 28
neoplasm metastasis (28) 28
receptors, estrogen - metabolism (28) 28
antineoplastic agents (27) 27
antineoplastic agents - administration & dosage (27) 27
cells (27) 27
endocrine therapy (27) 27
immunohistochemistry (27) 27
oncology, experimental (27) 27
open-label (27) 27
randomized-trial (27) 27
time factors (27) 27
expression (26) 26
follow-up studies (26) 26
health aspects (26) 26
medicine (26) 26
research article (26) 26
adjuvant treatment (25) 25
doxorubicin (25) 25
receptor, erbb-2 - genetics (25) 25
surgery (25) 25
antimitotic agents (24) 24
erbb-2 protein (24) 24
mutation (24) 24
oligonucleotide array sequence analysis (24) 24
predictive value of tests (24) 24
receptors, estrogen - analysis (24) 24
skin and connective tissue diseases (24) 24
survival rate (24) 24
tamoxifen - therapeutic use (24) 24
trial (24) 24
antibodies, monoclonal - therapeutic use (23) 23
biomarkers (23) 23
biomarkers, tumor - genetics (23) 23
neoadjuvant therapy (23) 23
prospective studies (23) 23
antineoplastic agents, hormonal - therapeutic use (22) 22
breast neoplasms - diagnosis (22) 22
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2009, 1. Aufl., Cancer treatment and research, ISBN 0387751149, Volume 151, xvi, 490
Adjuvant treatment is administered prior to or as follow up to surgical procedures for breast cancer. Proven success in using medical therapies allowing for... 
Breast | Adjuvant treatment | Cancer | Treatment | Oncology | Cancer Research | Medicine & Public Health | Surgical Oncology
Book
Nature Reviews Cancer, ISSN 1474-175X, 07/2007, Volume 7, Issue 7, pp. 545 - 553
The advent of microarray technology has enabled scientists to simultaneously investigate the expression of thousands of genes. Gene-expression profiling... 
Breast Neoplasms - classification | Neoplasms - therapy | Algorithms | Breast Neoplasms - genetics | Prognosis | Neoplasms - genetics | Oligonucleotide Array Sequence Analysis | Humans | Female | Gene Expression Profiling | Decision Trees | Care and treatment | Usage | DNA microarrays | Breast cancer | Genetic aspects | Diagnosis | Gene expression | Health aspects
Journal Article
Lancet, The, ISSN 0140-6736, 2017, Volume 389, Issue 10075, pp. 1195 - 1205
Journal Article
Lancet, The, ISSN 0140-6736, 2013, Volume 382, Issue 9897, pp. 1021 - 1028
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2013, Volume 31, Issue 7, pp. 860 - 867
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2011, Volume 12, Issue 3, pp. 236 - 244
Journal Article
NATURE REVIEWS CANCER, ISSN 1474-175X, 07/2007, Volume 7, Issue 7, pp. 545 - 553
The advent of microarray technology has enabled scientists to simultaneously investigate the expression of thousands of genes. Gene-expression profiling... 
HISTOLOGICAL GRADE | PROGNOSTIC SIGNATURE | PREOPERATIVE CHEMOTHERAPY | METASTASIS | TUMOR-MARKERS | ONCOLOGY | BREAST-CANCER PATIENTS | PERSONALIZED MEDICINE | MICROARRAY PLATFORMS | PROGRESSION | PREDICTION
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2008, Volume 26, Issue 5, pp. 729 - 735
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 6/2010, Volume 107, Issue 22, pp. 10208 - 10213
PIK3CA mutations are reported to be present in approximately 25% of breast cancer (BC), particularly the estrogen receptor—positive (ER+) and... 
Datasets | Health outcomes | Prognosis | Cell lines | Breast cancer | Signatures | Gene expression | Genetic mutation | Tumors | Cancer | Gene expression profiling | PI3 kinase | MOLECULAR SUBTYPES | TYROSINE PHOSPHORYLATION | MULTIDISCIPLINARY SCIENCES | PTEN | 3-KINASE MUTATIONS | AKT | EXPRESSION PROFILES | TUMORS | INSULIN-RECEPTOR | PATHWAY | POOR-PROGNOSIS | gene expression profiling | Neoplasms, Hormone-Dependent - metabolism | Receptors, Estrogen - metabolism | Oligonucleotide Array Sequence Analysis | Humans | Multiprotein Complexes | Receptor, ErbB-2 - metabolism | DNA Primers - genetics | Gene Expression Profiling | Proto-Oncogene Proteins c-akt - genetics | Breast Neoplasms - metabolism | Mechanistic Target of Rapamycin Complex 1 | Neoplasms, Hormone-Dependent - genetics | Proteins | Antineoplastic Agents, Hormonal - therapeutic use | Base Sequence | Female | Sirolimus - therapeutic use | Signal Transduction | Breast Neoplasms - drug therapy | Phosphatidylinositol 3-Kinases - genetics | Transcription Factors - metabolism | Breast Neoplasms - genetics | Class I Phosphatidylinositol 3-Kinases | Antibiotics, Antineoplastic - therapeutic use | Tamoxifen - therapeutic use | Cell Line, Tumor | TOR Serine-Threonine Kinases | Mutation | Neoplasms, Hormone-Dependent - drug therapy | Receptors | Analysis | Estrogen | Genetic aspects | Research | Properties | Tamoxifen | Protein kinases | Health aspects | TOR protein | Transformation | Exons | Estrogens | AKT protein | Data processing | 1-Phosphatidylinositol 3-kinase | Signal transduction | Biological Sciences
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2011, Volume 12, Issue 12, pp. 1134 - 1142
Journal Article